Item 4 — Purpose of Transaction
Founder Shares On January 6, 2026, the Sponsor acquired an aggregate of 4,791,667 ordinary shares, for $25,000, or approximately $0.005 per share (including an aggregate of up to 625,000 shares subject to forfeiture depending on the extent to which the underwriters' over-allotment option is exercised) ("Founder Shares"), pursuant to the Securities Subscription Agreement dated as of January 6, 2026 between the Sponsor and the Issuer (the "Founder Share Purchase Agreement") as more fully described in Item 6 of this Section 13D, which information is incorporated by reference. On June 4, 2026, upon the consummation of the initial public offering ("IPO") of the Issuer and the third-party investors purchasing 127,500 private placement units from the Issuer, Sponsor transferred an aggregate of 1,147,500 Founder Shares to such third-party investors on the same day. On June 10, 2026, the underwriters partially exercised their over-allotment option in connection with the IPO and as a result, 12,500 Founder Shares were forfeited by the Sponsor. As a result of the foregoing, Sponsor holds 3,631,667 Founder Shares of the Issuer as of June 11, 2026. Private Placement Units On June 2, 2026, simultaneously with the consummation of the Issuer's IPO, the Sponsor purchased 247,500 private placement units ("Placement Units") of the Issuer at $10.00 per Placement Unit, pursuant to a Private Placement Units Purchase Agreement, dated as of June 2, 2026, by and between the Issuer and the Sponsor (the "Private Placement Units Purchase Agreement"), as more fully described in Item 6 of this Schedule 13D, which information is incorporated herein by reference. Each Placement Unit consists of one ordinary share ("Placement Share") and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Issuer's business combination ("Business Combination") ("Placement Share Right"). On June 10, 2026, the underwriters partially exercised their over-allotment option in connection with the IPO and as a result, Sponsor received an additional 34,912 Placement Units. As a result, Sponsor holds 282,412 Placement Units as of June 11, 2026. The foregoing description of the Founder Share Purchase Agreement and the Private Placement Units Purchase Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the agreements, which are attached as exhibits hereto and incorporated herein by reference. The ordinary shares owned by the Reporting Persons have been acquired for investment purposes. The Reporting Persons may make further acquisitions of the ordinary shares from time to time and, subject to certain restrictions, may dispose of any or all of the ordinary shares held by the Reporting Persons at any time depending on an ongoing evaluation of the investment in such securities, prevailing market conditions, other investment opportunities and other factors. However, certain of such shares are subject to certain lock-up restrictions as further described in Item 6 below. Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) and (c) through (j) of Item 4 of Schedule 13D. With respect to paragraph (b) of Item 4, the Issuer is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Under various agreements between the Issuer and the Reporting Persons as further described in Item 6 below, the Reporting Persons have agreed (A) to vote their shares in favor of any proposed Business Combination and (B) not to redeem any shares in connection with a shareholder vote (or tender offer) to approve (or in connection with) a proposed initial Business Combination. The Reporting Persons may, at any time and from time to time, review or reconsider their position, change their purpose or formulate plans or proposals with respect to the Issuer.